部署報告





圖形 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

圖形 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

表 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

Date
Export Countries
2020 2021 2022 2023 2024 2025
義大利 2.927.000 2.998.000 2.832.000 6.469.000 4.854.000 1.413.000
中國大陸 2.421.000 2.970.000 3.309.000 4.560.000 4.485.000 2.269.000
荷蘭 146.000 44.000 7.000 262.000 11.440.000
美國 1.596.000 3.230.000 1.618.000 1.085.000 1.745.000 201.000
印度 1.119.000 926.000 673.000 1.144.000 1.631.000 360.000
墨西哥 460.000 1.435.000 301.000 286.000 530.000 1.041.000
法國 310.000 192.000 322.000 181.000 548.000 104.000
瑞典 503.000 287.000 135.000 190.000 222.000 133.000
以色列 12.000 536.000 565.000 34.000 313.000 9.000
德國 252.000 216.000 270.000 195.000 438.000 49.000
Others 2.474.000 937.000 1.125.000 522.000 741.000 413.000
Total 12,220,000 13,771,000 11,157,000 14,928,000 26,947,000 5,992,000

圖形 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

圖形 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

表 - 台灣 - 進口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

Date
Export Countries
11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025 04 - 2025
中國大陸 136.000 444.000 653.000 419.000 653.000 544.000
義大利 546.000 415.000 318.000 52.000 540.000 503.000
墨西哥 662.000 379.000
印度 17.000 271.000 151.000 35.000 112.000 62.000
美國 348.000 36.000 33.000 64.000 70.000 34.000
瑞典 77.000 81.000 51.000 1.000
葡萄牙 56.000 95.000
馬爾他 131.000
法國 1.000 9.000 4.000 80.000 19.000 1.000
馬爾地夫 18.000 52.000 5.000 20.000
Others 20.000 26.000 9.000 16.000 93.000 50.000
Total 1,068,000 1,352,000 1,220,000 1,414,000 2,143,000 1,215,000

圖形 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

圖形 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

表 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

Date
Import Countries
2020 2021 2022 2023 2024 2025
美國 4.727.000 5.615.000 9.147.000 4.874.000 8.953.000 6.172.000
日本 5.740.000 7.789.000 5.875.000 6.924.000 7.554.000 3.049.000
奧地利 7.008.000 3.937.000 4.232.000 9.421.000 5.814.000 5.651.000
印度 2.962.000 3.736.000 6.552.000 5.320.000 2.491.000 1.672.000
中國大陸 1.313.000 2.976.000 2.817.000 5.525.000 7.474.000 1.118.000
加拿大 3.029.000 1.618.000 1.234.000 1.793.000 4.739.000 2.923.000
巴西 3.424.000 3.696.000 3.244.000 1.306.000 1.545.000 66.000
愛爾蘭 1.409.000 5.086.000 1.298.000 1.550.000 1.322.000 961.000
法國 1.321.000 1.782.000 3.128.000 796.000 2.333.000
克羅埃西亞 633.000 528.000 1.062.000 956.000 1.075.000 409.000
Others 9.671.000 7.941.000 7.664.000 6.909.000 7.257.000 3.990.000
Total 41,237,000 44,704,000 46,253,000 45,374,000 50,557,000 26,011,000

圖形 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

圖形 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

表 - 台灣 - 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

Date
Import Countries
11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025 04 - 2025
美國 43.000 608.000 5.080.000 208.000 654.000 230.000
奧地利 24.000 29.000 5.622.000
日本 92.000 1.244.000 1.181.000 1.581.000 287.000
加拿大 432.000 681.000 331.000 429.000 727.000 1.436.000
中國大陸 1.459.000 35.000 45.000 861.000 212.000
印度 134.000 118.000 317.000 351.000 473.000 531.000
比利時 1.917.000
愛爾蘭 547.000 20.000 941.000
法國 1.260.000
克羅埃西亞 148.000 3.000 114.000 59.000 117.000 119.000
Others 754.000 329.000 84.000 499.000 857.000 699.000
Total 3,086,000 4,825,000 7,201,000 8,029,000 5,350,000 5,431,000

圖形 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

圖形 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

表 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 全年 FOB USD

Date
Export Countries
2020 2021 2022 2023 2024 2025
Importaciones
義大利 2.927.000 2.998.000 2.832.000 6.469.000 4.854.000 1.413.000
中國大陸 2.421.000 2.970.000 3.309.000 4.560.000 4.485.000 2.269.000
荷蘭 146.000 44.000 7.000 262.000 11.440.000
美國 1.596.000 3.230.000 1.618.000 1.085.000 1.745.000 201.000
印度 1.119.000 926.000 673.000 1.144.000 1.631.000 360.000
墨西哥 460.000 1.435.000 301.000 286.000 530.000 1.041.000
法國 310.000 192.000 322.000 181.000 548.000 104.000
瑞典 503.000 287.000 135.000 190.000 222.000 133.000
以色列 12.000 536.000 565.000 34.000 313.000 9.000
德國 252.000 216.000 270.000 195.000 438.000 49.000
Others 2.474.000 937.000 1.125.000 522.000 741.000 413.000
Total 12,220,000 13,771,000 11,157,000 14,928,000 26,947,000 5,992,000

Date
Import Countries
2020 2021 2022 2023 2024 2025
Exportaciones
美國 4.727.000 5.615.000 9.147.000 4.874.000 8.953.000 6.172.000
日本 5.740.000 7.789.000 5.875.000 6.924.000 7.554.000 3.049.000
奧地利 7.008.000 3.937.000 4.232.000 9.421.000 5.814.000 5.651.000
印度 2.962.000 3.736.000 6.552.000 5.320.000 2.491.000 1.672.000
中國大陸 1.313.000 2.976.000 2.817.000 5.525.000 7.474.000 1.118.000
加拿大 3.029.000 1.618.000 1.234.000 1.793.000 4.739.000 2.923.000
巴西 3.424.000 3.696.000 3.244.000 1.306.000 1.545.000 66.000
愛爾蘭 1.409.000 5.086.000 1.298.000 1.550.000 1.322.000 961.000
法國 1.321.000 1.782.000 3.128.000 796.000 2.333.000
克羅埃西亞 633.000 528.000 1.062.000 956.000 1.075.000 409.000
Others 9.671.000 7.941.000 7.664.000 6.909.000 7.257.000 3.990.000
Total 41,237,000 44,704,000 46,253,000 45,374,000 50,557,000 26,011,000

圖形 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

圖形 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

表 - 台灣 - 進口 - 進化 / 出口 - 進化 - NCE: 激素 - hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: - 每月 FOB USD

Date
Export Countries
11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025 04 - 2025
Importaciones
中國大陸 136.000 444.000 653.000 419.000 653.000 544.000
義大利 546.000 415.000 318.000 52.000 540.000 503.000
墨西哥 662.000 379.000
印度 17.000 271.000 151.000 35.000 112.000 62.000
美國 348.000 36.000 33.000 64.000 70.000 34.000
瑞典 77.000 81.000 51.000 1.000
葡萄牙 56.000 95.000
馬爾他 131.000
法國 1.000 9.000 4.000 80.000 19.000 1.000
馬爾地夫 18.000 52.000 5.000 20.000
Others 20.000 26.000 9.000 16.000 93.000 50.000
Total 1,068,000 1,352,000 1,220,000 1,414,000 2,143,000 1,215,000

Date
Import Countries
11 - 2024 12 - 2024 01 - 2025 02 - 2025 03 - 2025 04 - 2025
Exportaciones
美國 43.000 608.000 5.080.000 208.000 654.000 230.000
奧地利 24.000 29.000 5.622.000
日本 92.000 1.244.000 1.181.000 1.581.000 287.000
加拿大 432.000 681.000 331.000 429.000 727.000 1.436.000
中國大陸 1.459.000 35.000 45.000 861.000 212.000
印度 134.000 118.000 317.000 351.000 473.000 531.000
比利時 1.917.000
愛爾蘭 547.000 20.000 941.000
法國 1.260.000
克羅埃西亞 148.000 3.000 114.000 59.000 117.000 119.000
Others 754.000 329.000 84.000 499.000 857.000 699.000
Total 3,086,000 4,825,000 7,201,000 8,029,000 5,350,000 5,431,000